PTX 2.44% 4.2¢ prescient therapeutics limited

Ann: PTX Appoints Former Array BioPharma Executive to Key Role, page-12

  1. 802 Posts.
    lightbulb Created with Sketch. 292
    We can see the bid price is slowly but steadily moving up, indicating that there is a sense of urgency in the buyers.

    Let's wait for market to re-rate it when PTX announces licensing deal or phase 1B/2 results from any of the PTX200 clinical trials. $1 may not be that difficult when herds come.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.